PHI vs INDB
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PHI · PLDT$18.26 ▲ 0.55%
INDB · Independent Bank$84.10 ▼ 0.36%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PHI +2.4%
- INDB +24.6%
Head to head
| Metric | PHI | INDB |
|---|---|---|
| Price | $18.26 | $84.10 |
| Change today | ▲ 0.55% | ▼ 0.36% |
| Market cap | $3.95B | $3.95B |
| Return, 3 months | -3.5% | +1.1% |
| Return, year to date | -9.3% | +17.9% |
| Return, 1 year | +2.4% | +23.2% |
| P/E (TTM) | 9.0 | 12.4 |
| P/B | 1.9 | 1.1 |
| P/E percentile vs own 5y | 21st | 31st |
| Dividend yield | 8.43% | 2.98% |
| Revenue growth (YoY, latest qtr) | +2.1% | +7.5% |
| Net profit growth (YoY) | -13.6% | +161.9% |
| Gross margin | 85.8% | – |
| Operating margin | 23.9% | – |
| Net margin | 12.5% | 32.3% |
| Return on equity | 21.5% | 9.3% |
| Analyst target vs. price | – | +12.6% |
| Analyst buy share | – | 67% |
| RSI (14) | 49 | 57 |
| 30-day volatility | 34.6% | 24.1% |
| Max drawdown, 1 year | -26.5% | -14.3% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- INDB is the largest of the group by market value.
- INDB has returned the most over the past year.
- PHI carries the lowest trailing P/E.
- PHI pays the highest dividend yield.
- INDB is growing revenue fastest.
- INDB keeps the most profit per dollar of sales.
- INDB has been the calmest stock over the last 30 days.